Investment management company Curreen Capital released its second-quarter 2026 Investor letter. A copy of the letter can be downloaded here. In the second quarter, the fund returned 22.26% compared to 15.20% for the S&P 500 Index. The performance was driven by active special case investments, including buying a tender offer, a merger-spinoff, and investments in affordable turnaround opportunities. The fund continues to hold spinoffs of reliable businesses at favorable price ratios and non-spinoff businesses that are undervalued compared to their downside valuation. In addition, please check the firm’s top five holdings to know its best picks in 2026.
In its Q2 2026 investor letter, Curreen Capital highlighted Fortrea Holdings Inc. (NASDAQ:FTRE). Fortrea Holdings Inc. (NASDAQ:FTRE) is a contract research organization that serves pharmaceutical, biotechnology, and medical device customers. On August 10, 2026, Fortrea Holdings Inc. (NASDAQ:FTRE) closed at $18.99 per share, reflecting a market capitalization of $1.81 billion and a year‑to‑date gain of 10.09%. Fortrea Holdings Inc. (NASDAQ:FTRE) posted a one‑month return of 5.32%, while its shares gained 159.78% over the past 52 weeks.”
Curreen Capital stated the following regarding Fortrea Holdings Inc. (NASDAQ:FTRE) in its Q2 2026 investor letter:
“Fortrea Holdings Inc. (NASDAQ:FTRE) helps its biotech and pharmaceutical customers to run clinical trials with the goal of receiving marketing authorization in the U.S. and other countries. Fortrea helps design the trials, recruit investigators and participants, prepare data for regulatory review, and other tasks needed to win the authorization to market new treatments. The company spun out of Labcorp in June 2023, and is attempting to turn around the business. Fortrea currently trades at a very attractive upside-to-downside ratio.”
Fortrea Holdings Inc. (NASDAQ:FTRE) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 36 hedge fund portfolios held Fortrea Holdings Inc. (NASDAQ:FTRE) at the end of the first quarter, up from 35 in the previous quarter. While we acknowledge the potential of Fortrea Holdings Inc. (NASDAQ:FTRE) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on thebest short-term AI stock.
Disclaimer : This story is auto aggregated by a computer programme and has not been created or edited by DOWNTHENEWS. Publisher: finance.yahoo.com
